0000000000425973

AUTHOR

V Righini

showing 3 related works from this author

Teriparatide (1-34) vs. parathyroid hormone (1-84) in women with severe postmenopausal osteoporosis: a randomized, head-to-head study.

2009

teriparatide parathyroid hormone osteoporosis menopauseSettore MED/09 - Medicina Interna
researchProduct

VITAMIN D SUBSTRATE-PRODUCT RELATIONSHIP IN IDIOPATHIC HYPERCALCIURIA

2009

Absorptive hypercalciuria (AH) is associated with elevated levels of 1,25-dihydroxyvitamin D (1,25(OH)(2)D). While no increase of 1,25(OH)(2)D after oral administration of 25-hydroxyvitamin D (25OHD) at high doses has been claimed in normal subjects, a substrate-product relationship has been reported in normal children, young people after UV irradiation, older persons, postmenopausal women, primary hyperparathyroidism, renal failure, osteomalacia, and sarcoidosis. No data of this relationship in AH is available. To investigate 25OHD-1,25(OH)(2)D substrate-product relationship in AH, 161 AH patients (mean age 60.9+/-11.7 years) and 110 age- and sex-matched controls (mean age 61.5+/-12.4 year…

Settore MED/09 - Medicina Internavitamin d hypercalciuria kidney stones
researchProduct

TREATMENT WITH DAILY SUBCUTANEOUS TERIPARATIDE (1-34) COMPARED WITH DAILY SUBCUTANEOUS PARATHYROID HORMONE (1-84) IN WOMEN WITH SEVERE POSTMENOPAUSAL…

2008

TERIPARATIDE PARATHYROID HORMONE OSTEOPOROSIS BONE TURNOVER BMDSettore MED/09 - Medicina Interna
researchProduct